0001171843-18-004582.txt : 20180611 0001171843-18-004582.hdr.sgml : 20180611 20180611163331 ACCESSION NUMBER: 0001171843-18-004582 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180608 FILED AS OF DATE: 20180611 DATE AS OF CHANGE: 20180611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HASTINGS PAUL J CENTRAL INDEX KEY: 0001309702 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36694 FILM NUMBER: 18892375 MAIL ADDRESS: STREET 1: 61 HARTFORD STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-890-0102 MAIL ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 formfour.xml OWNERSHIP DOCUMENT X0306 4 2018-06-08 0 0001359931 PROTEON THERAPEUTICS INC PRTO 0001309702 HASTINGS PAUL J C/O PROTEON THERAPEUTICS, INC. 200 WEST STREET WALTHAM MA 02451 1 0 0 0 Stock Option (Right to Buy) 2.50 2018-06-08 4 A 0 12700 0 A 2028-06-07 Common Stock 12700 12700 D The options were granted on June 8, 2018 and the shares underlying this option will vest 100% at the earlier of (i) June 8, 2019 and (ii) the Issuer's next annual meeting of stockholders. /s/ George A. Eldridge, attorney-in-fact for Paul J. Hastings 2018-06-11